Progyny Inc.’s recent filing unveils that its Director Payson Norman unloaded Company’s shares for reported $11258.0 on Nov 23. In the deal valued at $56.29 per share,200 shares were sold. As a result of this transaction, Payson Norman now holds 580,656 shares worth roughly $ 20.25 million.
Then, TPG GP A, LLC sold 2,900,000 shares, generating $119,132,000 in total proceeds. Upon selling the shares at $41.08, the Former 10% Owner now owns 6,350,000 shares.
Before that, Anevski Peter sold 17,990 shares. Progyny Inc. shares valued at $700,710 were divested by the CHIEF EXECUTIVE OFFICER at a price of $38.95 per share. As a result of the transaction, Anevski Peter now holds 207,947 shares, worth roughly $7.25 million.
BTIG Research initiated its Progyny Inc. [PGNY] rating to a Buy in a research note published on Monday, May 22, 2023; the price target was $50. PT values the company’s stock at a premium of 30.26 to its Monday closing price.
Price Performance Review of PGNY
On Monday, Progyny Inc. [NASDAQ:PGNY] saw its stock jump 1.93% to $34.87. On the same session, the stock had its day’s lowest price of $33.96, but rose to a high of $34.94. Over the last five days, the stock has lost -5.93%. Progyny Inc. shares have risen nearly 11.94% since the year began. Nevertheless, the stocks have fallen -17.60% over the past one year. While a 52-week high of $45.98 was reached on 08/04/23, a 52-week low of $28.03 was recorded on 01/06/23. SMA at 50 days reached $38.43, while 200 days put it at $35.32. A total of 0.83 million shares were traded, compared to the trading of 0.85 million shares in the previous session.
Levels Of Support And Resistance For PGNY Stock
The 24-hour chart illustrates a support level at 34.24, which if violated will result in even more drops to 33.61. On the upside, there is a resistance level at 35.22. A further resistance level may holdings at 35.57. The Relative Strength Index (RSI) on the 14-day chart is 37.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.87, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.98%. Stochastics %K at 8.99% indicates the stock is a buying.
How much short interest is there in Progyny Inc.?
A steep rise in short interest was recorded in Progyny Inc. stocks on Aug 30, 2023, dropping by -0.31 million shares to a total of 5.41 million shares. Yahoo Finance data shows the prior-month short interest on Jul 30, 2023 was 5.72 million shares. There was a decline of -5.73%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 6.91% of the overall stock float, the days-to-cover ratio (short ratio) fell to 7.14.
Progyny Inc. [PGNY] – Who Are The Largest Shareholders?
In filings from BlackRock Fund Advisors, it is revealed that the company now owns 8,330,287 shares, or roughly 8.73% of the outstanding PGNY shares. In other words, the investor’s shares have risen by 39,046 from its previous 13-F filing of 8291241.0. Additionally, The Vanguard Group, Inc. increased 1.86% of its stake after which the total value it holdings stand at $275,132,733, while ClearBridge Investments LLC reduced -1.70% of its stake to hold $151.11 million in the firm. Over the last quarter, Weatherbie Capital LLC sold -136,393 shares of Progyny Inc., while SSgA Funds Management, Inc. sold 57,106 shares. At present, JPMorgan Investment Management, I is holding 2,486,528 shares valued at $92.85 million. Thrivent Asset Management LLC owned 2,271,496 shares of the company at the time of its most recent 13F filing, worth $84.82 million.
According to FactSet, Progyny Inc.’s share price will average $49.67 in the next year, based on opinions of analysts polled by the firm. This is up nearly 46.16 percent from its previous closing price of $34.21. Analysts expect Progyny Inc. stock to reach the higher price of $52.00, while the lowest price estimate is $47.00. However, 6 analysts have rated PGNY stock as a Buy in their predictions for 2023.